Clinically isolated syndrome (CIS) patients with high CSF levels of CHI3L1 have been reported to have a four times higher risk for the development of neurological disability, compared to CIS subjects with low CSF CHI3L1 levels (Canto et al., 2015). Here, CHI3L1 is linked to in situ carcinoma.